AngioDynamics, Inc. (ANGO)

Market Cap	494.35M +27.0%
Revenue (ttm)	313.73M +10.7%
Net Income	-31.39M
EPS	-0.76
Shares Out	41.68M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	60,294
Open	11.32
Previous Close	11.20
Day's Range	11.29 - 11.82
52-Week Range	8.36 - 13.99
Beta	0.36
Analysts	Strong Buy
Price Target	18.00 (+51.77%)
Earnings Date	Jul 14, 2026

About ANGO

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company’s thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device tha...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 27, 2004
• Employees: 675
• Stock Exchange: NASDAQ
• Ticker Symbol: ANGO
• Website: https://www.angiodynamics.com

Financial Performance

In fiscal year 2025, AngioDynamics's revenue was $292.50 million, a decrease of -3.76% compared to the previous year's $303.91 million. Losses were -$33.99 million, -81.56% less than in 2024.

Analyst Summary

According to 4 analysts, the average rating for ANGO stock is "Strong Buy." The 12-month stock price target is $18.0, which is an increase of 51.77% from the latest price.

Price Target

$18.0

(51.77% upside)

Analyst Consensus: Strong Buy